On 3 May 2024, Indian-headquartered Lupin, in partnership with Sandoz, announced its Canadian launch of etanercept biosimilar Rymti®, biosimilar to…...
Last week, the Associated Press reported that the U.S. Drug Enforcement Administration would move to reclassify marijuana (cannabis), moving it from…...
My colleague, Greg Levine, who Chairs our FDA regulatory compliance practice, and I had a very informative conversation in a webinar on 30 April 2024…...